The present study was undertaken to clarify the effect of group I
metabotropic glutamate receptor (mGluR) antagonist, (RS)-1-aminoindan-1,5-dicarboxylic
acid (AIDA) on pentetrazol-induced kindled
seizures. The mechanism of the
anticonvulsant effect of AIDA was also studied. Mice were anesthetized with
pentobarbital; the
electrodes and guide
cannula were chronically implanted into the cortex and lateral ventricle. In order to induce kindling, pentetrazol at a dose of 40 mg/kg was injected intraperitoneally once every 48 h. Behavioral and electroencephalographic (EEG)
seizures were observed for 20 min following pentetrazol administration. Intracerebroventricular (i.c.v.) injection of AIDA (1000 nmol/site) resulted in a significant inhibitory effect on pentetrazol-induced kindled
seizures, and this effect was antagonized by a group I mGluR agonist, (RS)-3,5-dihydroxyphenylglycine ((RS)-3,5-DHPG). The effect of AIDA (200 nmol/site) on pentetrazol-induced kindled
seizures was augmented by the simultaneous use of
gamma-aminobutyric acid (
GABA) mimetic drugs, such as
NNC-711 and
diazepam. Moreover, the effect of AIDA (1000 nmol/site) on pentetrazol-induced kindled
seizures was antagonized by a
GABA(A) receptor antagonist,
bicuculline and a
GABA(C) receptor antagonist, (1,2,5,6-tetrahydropyridin-4-yl)
methylphosphinic acid (TPMPA). It can be concluded that AIDA had an
anticonvulsant effect on pentetrazol-induced kindled
seizures, which was partially mediated by the GABAergic mechanism through
GABA(A) and
GABA(C) receptors.